LOG IN
Analysis
Featured Analysis
Articles by Category
Current Editions
Data Graphics
Discovery & Translation
Hot Topics
Podcasts & Webcasts
Special Reports & Presentations
White Papers
BCIQ Data
BCIQ
Company Profiles
Product Profiles
Target Profiles
Financial Dashboards
Events
All Events
BioCentury-BayHelix China Healthcare Summit
East-West Healthcare Reception
BioCentury-BayHelix East-West Summit
Bio€quity Europe
BioCentury Grand Rounds Inquiry
The BioCentury Show
Webinars - Upcoming & On-Demand
My Workspace
About BioCentury
Management
Analysts & Research Team
Scientific Advisory Board
Contact
Contact Us
Forgot Password
Request a Subscription
Sponsorship & Branding Inquiry
Media Kit
Request BioCentury's BCIQ Brochure
Customer Resource Center
Career Opportunities
Request a Trial
Company Profiles
Target Profiles
Product Profiles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Company Profiles
Target Profiles
Product Profiles
China Healthcare Summit
Bio€quity Europe
Explore BCIQ profiles by entering a company name.
REQUEST A FREE TRIAL
Overview
Mda
BioCentury
|
Jun 28, 2024
Regulation
Approval of Sarepta DMD gene therapy revives questions on FDA interactions with companies, patient advocates
CBER Director Marks met with biopharma companies, industry-funded advocates while considering gene therapy application
Read More
BioCentury
|
Mar 9, 2024
Discovery & Translation
Science spotlight: Elixirgen’s full-length dystrophin gene therapy, Insilico’s TNIK inhibitor and more
BioCentury’s roundup of translational innovations
Read More
BioCentury
|
Jun 16, 2023
Product Development
Patient organizations take on gene therapy’s redosing problem
If successful, a clinical trial funded by CureDuchenne,
MDA
and PPMD could have industry-wide consequences for gene therapy
Read More
BioCentury
|
May 1, 2023
Deals
Maze-Sanofi deal in Pompe shows how early clinical data can drive pharma deals
Pharma extends rare disease franchise, paying well-funded biotech $150M in cash and equity investment to embrace substrate reduction approach
Read More
BioCentury
|
Jul 2, 2021
Distillery Therapeutics
Targeting SDCBP in metastatic breast cancer
Read More
BioCentury
|
Apr 16, 2021
Politics, Policy & Law
Pandemic pain: how COVID-19 has devastated patient groups
Patient groups that are an essential part of the life sciences ecosystem are suffering from increased demands and decreased funding
Read More
BioCentury
|
Jul 13, 2018
Clinical News
Filgotinib meets in Phase II for psoriatic arthritis
Read More
BioCentury
|
Apr 20, 2018
Company News
Target ALS and partners launch biomarker study
Read More
BioCentury
|
Apr 19, 2018
Company News
Target ALS, partners launch biomarker study
Read More
BioCentury
|
May 26, 2014
Clinical News
Aldeyra Therapeutics preclinical data
Read More
Items per page:
10
1 - 10 of 85